Zoom: Analysts Anticipate $906 Million In Q1 Revenues

Zoom Video Communications (NASDAQ: ZM) will be reporting their first quarter financial results June 1st after market close. Analysts have a consensus $426.02 12-month price target on the company, via a total of 26 analysts, with seven analysts having strong buy ratings, five analysts having buy ratings, 13 have hold ratings and one analyst has a strong sell rating. The street high is an $550 price target from BTIG, and the lowest target sits at $250.

21 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 21 analysts is $906.03 million; this number has been revised upwards from $838.30 million at the start of the year. The highest revenue estimate is $918.9 million, while the lowest is $738.38 million.

The analyst consensus for net income for the first quarter is $297.60 million, this is up from the start of the year at $232.18 million. The highest net income estimate is $314 million, while the lowest is $292 million.

Onto EBITDA estimates, there are currently only 7 analysts who have first quarter EBITDA estimates. The mean is currently $318.06 million, with this number having been revised higher from $256.32 million at the start of the year. The street high estimate currently sits at $332 million in EBITDA and the lowest is $305.34 million.

Analysts estimate that quarterly earnings per share will come in at $0.61, with this number being higher than the $0.44 estimate at the start of the year. The street high is $0.70 and the lowest estimate is $0.46 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Kirkland Lake Drills 121 Metres Of 1.01 g/t Gold At Mirado

Cambria Gold To Spin Out Mt. Margaret Copper-Gold Project Into US-Focused Entity

Related News

HEXO: Canaccord Lowers Price Target Following Redecan Transaction Announcement

On May 28th, Hexo Corp (TSX: HEXO) (NYSE: HEXO) announced yet another acquisition. The company...

Tuesday, June 1, 2021, 11:51:00 AM

BMO, Canaccord Lower Targets On Xebec Adsorption After Margins Continue To Disappoint

On August 12, Xebec Adsorption Inc. (TSX: XBC) announced its second-quarter financial results. The company...

Monday, August 16, 2021, 04:42:00 PM

Salesforce: Analysts Maintain Ratings Following Slack Acquisition Announcement

On December 1st, Salesforce.com (NYSE: CRM) announced a definitive agreement to buy Slack (NYSE: WORK)...

Thursday, December 3, 2020, 02:31:00 PM

Canaccord Raises Sundial’s Price Target To $0.40, Casts Doubt On Zenabis

After a very busy and dilutive December, where shares outstanding went from 485.5 million to...

Monday, January 4, 2021, 11:11:00 AM

Well Health: Canaccord Slashes Price Target To $6

On May 11th, WELL Health Technologies Corp. (TSX: WELL) reported its first quarter financial results....

Wednesday, May 25, 2022, 04:11:00 PM